Revisto

AI-powered pharma marketing compliance

Austin, Texas, United States

Revisto is an AI-powered platform specializing in automating Medical, Legal, and Regulatory (MLR) review for pharmaceutical and life sciences companies. The platform claims to cut review cycles by 90%, leading to estimated annual savings of $15 million or more per brand.

Shareable draft

Check out Revisto on @MedStartr Today Revisto is an AI-powered platform specializing in automating Medical, Legal, and Regulatory (MLR) review for pharmaceutical and life sciences companies. The platform claims to cut review cycles by 90%, leading to estimated annual savings of $15 million or more per brand. #MentalBehavioralHealth #ClinicalDocumentation #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/FdVzLe9EuU8

Get Involved in Revisto

Problem Statement

Pharmaceutical and life sciences companies face time-consuming, error-prone Medical, Legal, and Regulatory (MLR) review processes.

Core Technology

AI and machine learning, continuously trained on FDA regulations (CFR 21) and global guidelines.

Key Differentiators

Integrates with Veeva Vault PromoMats

Company Info

Business Model: B2B SaaS
Founded: 2024
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.revisto.com/

Disease Areas

Mental Health

Technologies

Machine LearningAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Deployed with Big Pharma early adopters. Integrates real-time FDA 21 CFR regulations. Trained on proprietary terabytes of pharmaceutical marketing and clinical data.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Revisto?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.